A. Sanders
Director/Board Member presso BIOCRYST PHARMACEUTICALS, INC.
Patrimonio netto: 130 129 $ in data 31/03/2024
Profilo
A.
Machelle Sanders is an Independent Director at BioCryst Pharmaceuticals, Inc. and the Secretary at The North Carolina Department of Commerce.
She previously served as an Independent Director at Radius Health, Inc., NVN Liquidation, Inc., and the North Carolina Department of Administration.
She was also the Director at The North Carolina Biotechnology Center and the Vice President-Manufacturing & General Manager at Biogen, Inc. Ms. Sanders holds an undergraduate degree from North Carolina State University and a graduate degree from Pfeiffer University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
15/06/2023 | 25 611 ( 0.01% ) | 130 104 $ | 31/03/2024 | |
NVN LIQUIDATION INC
0.09% | 27/06/2023 | 25 248 ( 0.09% ) | 25 $ | 31/03/2024 |
Posizioni attive di A. Sanders
Società | Posizione | Inizio |
---|---|---|
BIOCRYST PHARMACEUTICALS, INC. | Director/Board Member | 08/02/2022 |
The North Carolina Department of Commerce | Corporate Secretary | 01/02/2021 |
Precedenti posizioni note di A. Sanders
Società | Posizione | Fine |
---|---|---|
NVN LIQUIDATION, INC. | Director/Board Member | 27/09/2023 |
RADIUS HEALTH, INC. | Director/Board Member | 15/08/2022 |
North Carolina Department of Administration | Corporate Secretary | 01/02/2021 |
The North Carolina Biotechnology Center
The North Carolina Biotechnology Center Internet Software/ServicesTechnology Services The North Carolina Biotechnology Center provides research and education grants. Its services include financing, technology assessment, business planning, and marketing strategies implementation. The company was founded in 1984 and is headquartered in Research Triangle Park, NC. | Director/Board Member | 01/01/2015 |
BIOGEN INC. | Corporate Officer/Principal | 01/01/2015 |
Formazione di A. Sanders
North Carolina State University | Undergraduate Degree |
Pfeiffer University | Graduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
BIOGEN INC. | Health Technology |
NVN LIQUIDATION, INC. | Health Technology |
Aziende private | 5 |
---|---|
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
The North Carolina Biotechnology Center
The North Carolina Biotechnology Center Internet Software/ServicesTechnology Services The North Carolina Biotechnology Center provides research and education grants. Its services include financing, technology assessment, business planning, and marketing strategies implementation. The company was founded in 1984 and is headquartered in Research Triangle Park, NC. | Technology Services |
The North Carolina Department of Commerce | Government |
North Carolina Department of Administration | Government |
Research Triangle Park |
- Borsa valori
- Insiders
- A. Sanders